Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy (Q34022851)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Benjamin Nisman

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Vladimir Yutkin

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hovav Nechushtan

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ofer N Gofrit

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Tamar Peretz

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Simon Gronowitz

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dov Pode

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

22 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

513.e1-6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

NCCN clinical practice guidelines in oncology: kidney cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Regulation and biological function of thymidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

The role of hypoxia-induced factors in tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

The pyruvate kinase isoenzyme M2 (Tu M2-PK) as a tumour marker for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Pyruvate kinase type tumor M2 in urological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Tumour necrosis in chromophobe renal cell carcinoma: clinical data to distinguish aggressive variants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Tumor M2 pyruvate kinase in plasma of patients with urological tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Tumor hypoxia and cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Expression of hypoxia-inducible genes in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Adjuvant therapy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.04.034

7 January 2021

Identifiers

10.1016/J.UROLOGY.2010.04.034

1 reference

https://api.fatcat.wiki/v0/release/te555cryx5hvxbwk57zba7ng6e

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_te555cryx5hvxbwk57zba7ng6e

1 reference

https://api.fatcat.wiki/v0/release/te555cryx5hvxbwk57zba7ng6e

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/te555cryx5hvxbwk57zba7ng6e

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34022851&oldid=1801779671"